Results 161 to 170 of about 48,129 (210)
Some of the next articles are maybe not open access.
American Journal of Clinical Pathology, 1982
An acquired circulating inhibitor to Factor VIII:C was found in a 27-year-old postpartum woman who presented with ecchymoses and hematomas. Postpartum Factor VIII:C inhibitors can clinically manifest with signs and symptoms not unlike those in a classic hemophiliac.
B S, Shitamoto +2 more
openaire +2 more sources
An acquired circulating inhibitor to Factor VIII:C was found in a 27-year-old postpartum woman who presented with ecchymoses and hematomas. Postpartum Factor VIII:C inhibitors can clinically manifest with signs and symptoms not unlike those in a classic hemophiliac.
B S, Shitamoto +2 more
openaire +2 more sources
Thrombosis and Haemostasis, 1961
SummaryHemophilia A is reported in a Shetland sheepdog. The history, clotting defects and clinical course were similar to that seen in human hemophilia. As far as we know, no evidence of hemophilia has been reported in this breed. Bleeding episodes could be controlled by fresh frozen plasma given either intravenously or intraperitoneally.Due to the ...
H A, WURZEL, W C, LAWRENCE
openaire +2 more sources
SummaryHemophilia A is reported in a Shetland sheepdog. The history, clotting defects and clinical course were similar to that seen in human hemophilia. As far as we know, no evidence of hemophilia has been reported in this breed. Bleeding episodes could be controlled by fresh frozen plasma given either intravenously or intraperitoneally.Due to the ...
H A, WURZEL, W C, LAWRENCE
openaire +2 more sources
Seminars in Thrombosis and Hemostasis, 2012
Acquired hemophilia A is a rare, autoimmune disorder that is caused by autoantibodies that act as inhibitors to factor VIII. It is characterized by severe, unexpected bleeding that may be life-threatening. The incidence of acquired hemophilia A is ~ 0.2 to 1.48 cases per 1 million individuals per year.
openaire +2 more sources
Acquired hemophilia A is a rare, autoimmune disorder that is caused by autoantibodies that act as inhibitors to factor VIII. It is characterized by severe, unexpected bleeding that may be life-threatening. The incidence of acquired hemophilia A is ~ 0.2 to 1.48 cases per 1 million individuals per year.
openaire +2 more sources
Pediatric Blood & Cancer, 2012
AbstractClinical experience over decades and numerous retrospective and, recently, also prospective studies clearly demonstrate that prophylactic treatment, albeit much more expensive, is superior to on‐demand treatment regardless of whether the outcome is number of joint‐ or life‐threatening bleeds or arthropathy optimal prophylactic treatment should ...
openaire +2 more sources
AbstractClinical experience over decades and numerous retrospective and, recently, also prospective studies clearly demonstrate that prophylactic treatment, albeit much more expensive, is superior to on‐demand treatment regardless of whether the outcome is number of joint‐ or life‐threatening bleeds or arthropathy optimal prophylactic treatment should ...
openaire +2 more sources
2011
Acquired hemophilia A is a rare but often life-threatening hemorrhagic disorder characterized by an autoantibody directed against coagulation factor VIII. Fifty per cent of cases are idiopathic whereas the remaining 50% are associated with pregnancy, autoimmune conditions, malignancies and drugs.
Franchini M, LIPPI, Giuseppe
openaire +2 more sources
Acquired hemophilia A is a rare but often life-threatening hemorrhagic disorder characterized by an autoantibody directed against coagulation factor VIII. Fifty per cent of cases are idiopathic whereas the remaining 50% are associated with pregnancy, autoimmune conditions, malignancies and drugs.
Franchini M, LIPPI, Giuseppe
openaire +2 more sources
Oral Surgery, Oral Medicine, Oral Pathology, 1969
B M, Lyons, B J, Blankenship, R A, Stout
openaire +2 more sources
B M, Lyons, B J, Blankenship, R A, Stout
openaire +2 more sources
Management of hemophilia and hemophilia carriers
BloodAbstract Introduction: Historically, hemophilia has been viewed as primarily affecting individuals assigned male at birth (“males”) due to its X-linked inheritance, and individuals assigned female (“females”) being primarily referred to as hemophilia carriers.
Susan Lattimore, Kristina Haley
openaire +1 more source
Adeno-Associated Virus Gene Therapy for Hemophilia
Annual Review of Medicine, 2023Benjamin J Samelson-Jones +1 more
exaly